[1] Ahammad F, Rupa HS, Rashid AM and Rasul CH. Fanconi anemia. Bangladesh Medical Journal Khulna 2017;50 (1-2): 46-48. https://doi.org/10.3329/bmjk.v50i1-2.35844
[2] Deng S, Ye W, Zhang S, et al. Oral Tongue Cancer in a Patient with Fanconi Anemia: A Case Report and Literature Review. Cancer Manag Res. 2021;13:3145-3154. https://doi.org/10.2147/CMAR.S301582
[3] Guitton-Sert L, Gao Y, Masson JY. Animal models of Fanconi anemia: A developmental and therapeutic perspective on a multifaceted disease. Semin Cell Dev Biol. 2021;113:113-131.https://doi.org/10.1016/j.semcdb.2020.11.010
[4] Nepal M, Che R, Zhang J, Ma C, Fei P. Fanconi Anemia Signaling and Cancer. Trends Cancer. 2017;3(12):840-856. https://doi.org/10.1016/j.trecan.2017.10.005
[5] Jacquemont C, Taniguchi T. The Fanconi anemia pathway and ubiquitin. BMC Biochem. 2007;8 Suppl 1(Suppl 1):S10. Published 2007 Nov 22. https://doi.org/10.1186/1471-2091-8-S1-S10
[6] Fiesco-Roa MO, Giri N, McReynolds LJ, Best AF, Alter BP. Genotype-phenotype associations in Fanconi anemia: A literature review. Blood Rev. 2019;37:100589. https://doi.org/10.1016/j.blre.2019.100589
[7] Alter BP. Diagnosis, genetics, and management of inherited bone marrow failure syndromes. Hematology Am Soc Hematol Educ Program. 2007;29-39. https://doi.org/10.1182/asheducation-2007.1.29
[8] Balta G, Patiroglu T, Gumruk F. Fanconi Anemia and Ataxia Telangiectasia in Siblings who Inherited Unique Combinations of Novel FANCA and ATM Null Mutations. J Pediatr Hematol Oncol. 2019;41(3):243-246. https://doi.org/10.1097/MPH.0000000000001336
[9] Mundlos S and Horn D. Fanconi Anemia. In: editors. Limb Malformations. Springer; 2014. p. 193-194.
[10] Ben Haj Ali A, Messaoud O, Elouej S, et al. FANCA Gene Mutations in North African Fanconi Anemia Patients. Front Genet. 2021;12:610050. https://doi.org/10.3389/fgene.2021.610050
[11] Oostra AB, Nieuwint AW, Joenje H, de Winter JP. Diagnosis of fanconi anemia: chromosomal breakage analysis. Anemia. 2012;2012:238731. https://doi.org/10.1155/2012/238731
[12] Auerbach AD. Diagnosis of Fanconi anemia by diepoxybutane analysis. Curr Protoc Hum Genet. 2015;85:8.7.1-8.7.17. https://doi.org/10.1002/0471142905.hg0807s85
[13] Rodríguez A, Naveja JJ, Torres L, et al. WIP1 Contributes to the Adaptation of Fanconi Anemia Cells to DNA Damage as Determined by the Regulatory Network of the Fanconi Anemia and Checkpoint Recovery Pathways. Front Genet. 2019;10:411.https://doi.org/10.3389/fgene.2019.00411
[14] Nicoletti E, Rao G, Bueren JA, et al. Mosaicism in Fanconi anemia: concise review and evaluation of published cases with focus on clinical course of blood count normalization. Ann Hematol. 2020;99(5):913-924. https://doi.org/10.1007/s00277-020-03954-2
[15] Rodríguez A, Zhang K, Färkkilä A, et al. MYC Promotes Bone Marrow Stem Cell Dysfunction in Fanconi Anemia. Cell Stem Cell. 2021;28(1):33-47.e8. https://doi.org/10.1016/j.stem.2020.09.004
[16] Yabe M, Morio T, Tabuchi K, et al. Long-term outcome in patients with Fanconi anemia who received hematopoietic stem cell transplantation: a retrospective nationwide analysis. Int J Hematol. 2021;113(1):134-144. https://doi.org/10.1007/s12185-020-02991-x
[17] García MJ, Fernández V, Osorio A, et al. Analysis of FANCB and FANCN/PALB2 fanconi anemia genes in BRCA1/2-negative Spanish breast cancer families. Breast Cancer Res Treat. 2009;113(3):545-551.https://doi.org/10.1007/s10549-008-9945-0
[18] Tolar J, Becker PS, Clapp DW, et al. Gene therapy for Fanconi anemia: one step closer to the clinic. Hum Gene Ther. 2012;23(2):141-144. https://doi.org/10.1089/hum.2011.237
[19] Shafqat S, Tariq E, Parnes AD, Dasouki MJ, Ahmed SO, Hashmi SK. Role of gene therapy in Fanconi anemia: A systematic and literature review with future directions. Hematol Oncol Stem Cell Ther. 2021;14(4):290-301. https://doi.org/10.1016/j.hemonc.2021.02.001
[20]Czechowicz A, Agarwal R, Sevilla J, Río P and Roncarolo MG. Gene Therapy for Fanconi Anemia, Complementation Group a: Updated Results from Ongoing Global Clinical Studies of RP-L102. Blood .2020; 136: 14-14. https://doi.org/ 10.1182/blood-2020-137106
[21] Czechowicz A , Rio P , Bueren J E , et al. Changing the Natural History of Fanconi Anemia Complementation Group- with Gene Therapy: Early Results of U.S. Phase I Study of Lentiviral-Mediated Ex-Vivo FANCA Gene Insertion in Human Stem and Progenitor Cells. Biology of Blood and Marrow Transplantation, 2020, 26( 3) . https://doi.org/10.1016/ j.bbmt.2019.12.106
[22] Solanki A, Rajendran A, Mohan S, Raj R, Vundinti BR. Mitochondrial DNA variations and mitochondrial dysfunction in Fanconi anemia. PLoS One. 2020;15(1):e0227603.https://doi.org/10.1371/journal.pone.0227603
[23] Zhou Y, He Y, Xing W, et al. An abnormal bone marrow microenvironment contributes to hematopoietic dysfunction in Fanconi anemia. Haematologica. 2017;102(6):1017-1027. https://doi.org/10.3324/haematol.2016.158717
[24] Alhuraiji A, Alzahrani H, Al Mohareb F, et al. Hematopoietic Stem Cell Transplant in Adolescent and Young Adults With Fanconi Anemia Is Feasible With Acceptable Toxicity, With Those Surviving 100 Days Posttransplant Having Excellent Outcomes. Exp Clin Transplant. 2016;14(6):660-664. https://doi.org/10.6002/ect.2015.0364
[25] Strocchio L, Pagliara D, Algeri M, et al. HLA-haploidentical TCRαβ+/CD19+-depleted stem cell transplantation in children and young adults with Fanconi anemia. Blood Adv. 2021;5(5):1333-1339. https://doi.org/10.1182/bloodadvances.2020003707
[26] Zheng R, Wan C, Mei S, et al. Cistrome Data Browser: expanded datasets and new tools for gene regulatory analysis. Nucleic Acids Res. 2019;47(D1):D729-D735. https://doi.org/10.1093/nar/gky1094
[27] Bhandari J, Thada P K, Puckett Y. Fanconi anemia. StatPearls, 2021.
[28] Hou H, Li D, Gao J, et al. Proteomic profiling and bioinformatics analysis identify key regulators during the process from fanconi anemia to acute myeloid leukemia. Am J Transl Res. 2020;12(4):1415-1427. PMID: 32355551
[29] Degan P, Cappelli E, Longobardi M, et al. A Global MicroRNA Profile in Fanconi Anemia: A Pilot Study. Metab Syndr Relat Disord. 2019;17(1):53-59. https://doi.org/10.1089/met.2018.0085
[30] Bogliolo M, Pujol R, Aza-Carmona M, et al. Optimised molecular genetic diagnostics of Fanconi anaemia by whole exome sequencing and functional studies. J Med Genet. 2020;57(4):258-268. https://doi.org/10.1136/jmedgenet-2019-106249
[31] Velimezi G, Robinson-Garcia L, Muñoz-Martínez F, et al. Map of synthetic rescue interactions for the Fanconi anemia DNA repair pathway identifies USP48. Nat Commun. 2018;9(1):2280. https://doi.org/10.1038/s41467-018-04649-z
[32] Hou H, Li D, Yao YH, et al. Proteomic analysis for identifying the differences in molecular profiling between fanconi anaemia and aplastic anaemia. Am J Transl Res. 2019;11(10):6522-6533. PMID: 31737203
[33] Sertorio M, Amarachintha S, Wilson A, Pang Q. Loss of Fancc Impairs Antibody-Secreting Cell Differentiation in Mice through Deregulating the Wnt Signaling Pathway. J Immunol. 2016;196(7):2986-2994. https://doi.org/10.4049/jimmunol.1501056
[34] Myers KC, Sauter S, Zhang X, et al. Impaired immune function in children and adults with Fanconi anemia. Pediatr Blood Cancer. 2017;64(11):10.1002/pbc.26599. https://doi.org/10.1002/pbc.26599
[35] Justo GA, Bitencourt MA, Pasquini R, et al. Immune status of Fanconi anemia patients: decrease in T CD8 and CD56dim CD16+ NK lymphocytes. Ann Hematol. 2014;93(5):761-767. https://doi.org/10.1007/s00277-013-1953-4
[36] Wang Z, Wang Y, Peng M, Yi L. UBASH3B Is a Novel Prognostic Biomarker and Correlated With Immune Infiltrates in Prostate Cancer. Front Oncol. 2020;9:1517. https://doi.org/10.3389/fonc.2019.01517
[37] Cao H, Quan S, Zhang L, Chen Y, Jiao G. BMPR2 expression level is correlated with low immune infiltration and predicts metastasis and poor survival in osteosarcoma. Oncol Lett. 2021;21(5):391. https://doi.org/10.3892/ol.2021.12652